Table 1.
Clinicopathological correlation of circLMTK2 expression in gastric cancer
| No. | % | High expression | Low expression | P-value | |
|---|---|---|---|---|---|
| Gender | |||||
| Male | 90 | 81.1% | 45 | 45 | |
| Female | 21 | 18.9% | 11 | 10 | 0.846 |
| Age (years) | |||||
| ≤60 | 52 | 46.8% | 25 | 27 | |
| >60 | 59 | 53.2% | 31 | 28 | 0.642 |
| Tumor size (cm) | |||||
| ≤5 | 69 | 62.2% | 37 | 32 | |
| >5 | 42 | 37.8% | 19 | 23 | 0.396 |
| TNM stage | |||||
| I+II | 37 | 33.3% | 24 | 13 | |
| III+IV | 74 | 66.7% | 32 | 42 | 0.032 |
| Lymphatic vascular invasion | |||||
| No | 52 | 46.8% | 31 | 21 | |
| Yes | 59 | 53.2% | 25 | 34 | 0.071 |
| Nerve infiltration | |||||
| No | 53 | 47.7% | 28 | 25 | |
| Yes | 58 | 52.3% | 28 | 30 | 0.635 |
| Lymphatic metastasis | |||||
| No | 28 | 25.2% | 20 | 8 | |
| Yes | 83 | 74.8% | 36 | 47 | 0.010 |